These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21115941)

  • 41. Incidence and clinical significance of lymph node metastasis detected by cytokeratin immunohistochemical staining in ductal carcinoma in situ.
    El-Tamer M; Chun J; Gill M; Bassi D; Lee S; Hibshoosh H; Mansukhani M
    Ann Surg Oncol; 2005 Mar; 12(3):254-9. PubMed ID: 15827818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metastatic mammary carcinoma with DCIS-like morphology: a report of two cases.
    Coyne J
    Int J Surg Pathol; 2012 Oct; 20(5):485-7. PubMed ID: 22297833
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive bone marrow biopsy is associated with a decreased disease-free survival in patients with operable breast cancer.
    Fortunato L; Mascaro A; Baldi A; Farina M; Cortese G; Ventrone MA; Amini M; Vitelli C
    Ann Surg Oncol; 2009 Nov; 16(11):3010-9. PubMed ID: 19641970
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Invasive ductal carcinoma of the breast with a predominant intraductal component: cooperative clinicopathologic study in seven Japanese centers.
    Enjoji M; Matsukuma A; Sakamoto G; Toyoshima S; Hirota T; Wada A; Ishida T; Enomoto K; Koyama H; Yamamoto H
    Jpn J Clin Oncol; 1992 Apr; 22(2):84-91. PubMed ID: 1320141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients.
    Matsuura K; Yamaguchi Y; Osaki A; Ohara M; Okita R; Emi A; Murakami S; Arihiro K
    Oncol Rep; 2009 Nov; 22(5):1181-7. PubMed ID: 19787238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of recurrence of ductal carcinoma in situ by oncotype Dx technology: some concerns.
    Lagios MD; Silverstein MJ
    Cancer; 2014 Apr; 120(7):1085. PubMed ID: 24382657
    [No Abstract]   [Full Text] [Related]  

  • 47. Oncotype DX DCIS score predicts recurrence.
    Cancer Discov; 2015 Feb; 5(2):OF3. PubMed ID: 25656901
    [No Abstract]   [Full Text] [Related]  

  • 48. Expression of tenascin in invasion border of early breast cancer correlates with higher risk of distant metastasis.
    Jahkola T; Toivonen T; von Smitten K; Blomqvist C; Virtanen I
    Int J Cancer; 1996 Dec; 69(6):445-7. PubMed ID: 8980244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma.
    Clemente CG; Boracchi P; Andreola S; Del Vecchio M; Veronesi P; Rilke FO
    Cancer; 1992 Mar; 69(6):1396-403. PubMed ID: 1311623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential prognostic value of repulsive guidance molecules in breast cancer.
    Li J; Ye L; Mansel RE; Jiang WG
    Anticancer Res; 2011 May; 31(5):1703-11. PubMed ID: 21617229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and pathological characteristics of very young breast cancer patients (≤ 25 years of age).
    Ararat E; Sahin I; Arslan C; Aksoy S; Dizdar O; Ozisik Y; Altundag K
    J BUON; 2011; 16(2):372. PubMed ID: 21766514
    [No Abstract]   [Full Text] [Related]  

  • 52. Cathepsin D in breast cancer tissue.
    Gonzalez Gancedo P; G-Casaus ML; Ruiz Cacho J; Calero F; Inocente JM; Gomez-Pastrana F; Ramon N
    Int J Biol Markers; 1990; 5(4):203-6. PubMed ID: 1965545
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glutathione levels and variability in breast tumors and normal tissue.
    Perry RR; Mazetta JA; Levin M; Barranco SC
    Cancer; 1993 Aug; 72(3):783-7. PubMed ID: 8392905
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
    Hamamoto R; Silva FP; Tsuge M; Nishidate T; Katagiri T; Nakamura Y; Furukawa Y
    Cancer Sci; 2006 Feb; 97(2):113-8. PubMed ID: 16441421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of IGF-1 expression in the peripheral blood of women with recurrent breast cancer.
    Costa-Silva DR; Barros-Oliveira MDC; Alves-Ribeiro FA; Campos-Verdes LC; Nery Junior EJ; Vieira-Valença SF; Vasconcelos-Valença RJ; Soares VM; Pinho-Sobral AL; Sousa EB; Lopes-Costa PV; Dos Santos AR; Viana JL; Cardoso AC; Luz-Borges VM; Pereira RO; Tavares CB; Silva VC; Rodrigues-Junior DM; Gebrim LH; da Silva BB
    Medicine (Baltimore); 2020 Oct; 99(43):e22890. PubMed ID: 33120836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer.
    Alam SM; Whitford P; Cushley W; George WD; Campbell AM
    Br J Cancer; 1990 Aug; 62(2):238-42. PubMed ID: 2167120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Juvenile secretory carcinoma. 5 new cases in adult women].
    Tournemaine N; Audouin AF; Anguill C; Gordeeff S
    Arch Anat Cytol Pathol; 1986; 34(3):146-51. PubMed ID: 3539035
    [No Abstract]   [Full Text] [Related]  

  • 58. Comprehensive analysis of HE4 expression in normal and malignant human tissues.
    Galgano MT; Hampton GM; Frierson HF
    Mod Pathol; 2006 Jun; 19(6):847-53. PubMed ID: 16607372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Karnofsky Memorial Lecture. Natural history of small breast cancers.
    Hellman S
    J Clin Oncol; 1994 Oct; 12(10):2229-34. PubMed ID: 7931493
    [No Abstract]   [Full Text] [Related]  

  • 60. Metastatic bone disease developing in patients with potentially curable breast cancer.
    Robbins GF; Knapper WH; Barrie J; Kripalani I; Lawrence J
    Cancer; 1972 Jun; 29(6):1702-4. PubMed ID: 4337957
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.